ACT I

The embryo scored 9.2 on the HelixCorp Awakening Potential Index. Which meant it was probably going to be sold to a defense contractor.

Jack Calloway sat in his cubicle on the forty-second floor of the HelixCorp tower in lower Manhattan, staring at the genomic sequence on his monitor, and thought about his coffee going cold. The office air conditioning was set to sixty-eight degrees year-round, which meant any beverage not consumed within eight minutes was essentially water with delusions of grandeur.

"Another one," said Maria from two cubicles over. She didn't look up from her own screen. "That's the third 9-plus this week."

"Tell me about it." Jack rubbed his eyes and took a sip of coffee that was, predictably, just cold water now. "We're screening for evolution and turning out a conveyor belt of super-soldiers."

"You're supposed to sound enthusiastic about that."

"I am. Enthusiastic. About soldiers. Very enthusiastic."

He was not supposed to sound enthusiastic. His job description specifically stated that analysts should maintain "professional neutrality" when reviewing API scores. Not enthusiasm, not concern—just a steady, unfeeling stream of data entry. Select. Record. Submit. The human genome as a spreadsheet.

But Jack had been doing this job for four years and he had started to notice patterns. Not the obvious patterns—every analyst noticed that the highest scores clustered around certain ethnic markers and geographic regions. Those were flagged in quarterly reports and discussed in meetings with words like "population genetics" and "statistical significance." The patterns he noticed were smaller, quieter, more uncomfortable.

Like the fact that every embryo that scored above 9.0 had a specific variant in the COMT gene—the one that regulated dopamine breakdown in the prefrontal cortex. The variant was common enough in the general population, present in maybe fifteen percent of people. But in the API samples, it appeared in ninety-seven percent of the 9-plus embryos.

Like the fact that every single one of those embryos also carried a secondary marker: a deliberately inserted sequence in the MAOA gene promoter region that suppressed aggressive impulse pathways.

Jack called it the Ozzie Marker. Because it was the genetic equivalent of a suburban split-level: bright on the outside, predictably arranged within, designed to produce children who would grow up to be excellent employees and terrible decision-makers.

ACT II

His brother Marcus worked on the other side of the building, in Advanced Development. Jack hadn't seen him in six weeks. Marcus's job title was "Genomic Optimization Lead," which sounded important and meant he probably spent most of his day attending meetings about other people's jobs.

They had not always been distant. There was a time—Jack's childhood, Marcus's adulthood—when Marcus would walk him home from school, carrying his backpack because Jack's had somehow filled with more books than physically possible. Marcus was the good brother. The one who got into MIT at seventeen and never came back, except for holidays, except for phone calls that grew shorter and more formal with each passing year.

The phone rang at 4:47 PM on a Friday. Jack was packing his bag, thinking about the half-empty bottle of gin in his apartment cabinet and whether two glasses constituted a weekend or a crisis.

"Jack." Marcus's voice was different. flatter. The way it sounded when he was on company time.

"Marcus. What's up?"

"I need you to do something for me."

"I need you to do something for me, too. Namely stop putting your genetic modifications in publicly accessible databases. My job involves reviewing your data, and it's making my quarterly reviews very awkward."

"Not funny. I have a file—internal Advanced Development, clearance level four—and I need you to pull it. I can't access it from outside the network, and I can't ask anyone else to pull it because anyone else asking would trigger an audit, and an audit would—"

"You'd get in trouble?"

"I'd lose my security clearance. And my job. And access to the program."

Jack stared at his computer screen, at the embryo that had scored 9.2 and was probably going to be sold to someone who would use it to make things go bump in the night. "Why me?"

"Because you're the only person I know who can read genomic sequences without having a panic attack."

That wasn't true. Jack had never read a genomic sequence without a panic attack. He read them every day. The panic attack was just muted, like everything else. That was the Ozzie Marker at work—not just in the embryos, but in the people who managed them.

"What's in the file?" Jack asked.

"I don't know. That's why I need you to look at it."

ACT III

The file was labeled APOLLO-7 and contained three components: a list of twelve names, each accompanied by a genomic profile, and a set of instructions for each name.

Jack read the instructions twice. Then a third time, because the second time didn't make any more sense than the first.

The twelve names were "Awakened" individuals—people who had spontaneously activated the Frost Gene variant without any corporate intervention. Baseline humans who, for reasons unknown, had awakened naturally. They lived in seven different states, worked at seven different jobs, and according to the file's assessment, posed seven different levels of "strategic risk."

Four of them were classified as STRATEGIC RISK: HIGH. The instruction for each was identical: TERMINATE ACCESS. Coordinate with assigned handler. Ensure containment before activation threshold is reached.

The other eight were classified as LOW or NEGLIGIBLE. Their instructions read: MONITOR. Report anomalies. Do not intervene.

Jack sat in the blue glow of his monitor in the empty office building and felt something he hadn't felt in years. It wasn't anger. Anger required energy he didn't have. It wasn't fear. Fear required a belief that consequences mattered.

It was recognition.

He knew one of the twelve names. Not personally—everyone in the genetic screening industry knew Sarah Chen. She was a researcher at Stanford who had published a paper on spontaneous COMT variant activation in unmodified populations. The paper had been well-received, lightly cited, and then quietly buried by journals that answered to the same corporations who owned HelixCorp.

Sarah Chen was STRATEGIC RISK: HIGH.

Marcus was one of the twelve. His name appeared on the list with an API score of 9.8—the highest Jack had ever seen—and the instruction: MONITOR. DO NOT INTERVENE.

His brother was being watched by the people who employed him. His brother, who couldn't remember the last time they'd had a real conversation, who spoke in corporate jargon and scheduled family dinners like board meetings, was being monitored for the crime of being exceptionally, unavoidably himself.

Jack closed the file. He closed his laptop. He walked out of the HelixCorp tower and into the Manhattan night, where the city lights reflected off puddles and the subway rumbled beneath his feet like something alive and indifferent and very, very old.

He thought about uploading the file to every journalist, every regulator, every news outlet he could find. He thought about calling Sarah Chen at Stanford and telling her to run. He thought about going to Marcus's apartment and shaking him until he remembered who he used to be.

Instead, he went home, poured two glasses of gin, and sat in his apartment until the sun came up.

ACT IV

Jack Calloway submitted his resignation on Monday morning. He cited "personal reasons," which was the corporate equivalent of "I have a cat and it needs me," and HelixCorp processed it with the efficient indifference of a machine that expected to replace him within forty-eight hours.

He did not upload the APOLLO-7 file. He did not call Sarah Chen. He did not go to see Marcus.

On his last day in the office, he walked past Maria's cubicle one more time. "I'm out," he said.

She looked up from her screen, where another embryo scrolled past, scoring itself on a scale that determined whether it would be sold to a defense contractor or a pharmaceutical company or, in rarer cases, a university lab that actually wanted to help people.

"Good," she said. "Someone should."

He walked out of the building and into the Manhattan afternoon, carrying a cardboard box with a dying succulent and a mug that said WORLD'S OKAYEST ANALYST. He did not look back.

The city swallowed him the way cities do: without malice, without generosity, with a steady, mechanical throughput of bodies moving from one point to another, each one carrying its own genome, its own history, its own quiet act of rebellion against the expectation that it should be anything other than what it was.

Jack Calloway was a baseline human in a world that increasingly devalued baselines. He was ninety-seven percent obsolete by API standards. He was, he decided as he crossed Fifth Avenue and watched a bus spray puddle water onto the sidewalk, perfectly sufficient.

OTMES V2 Objective Codes - Tragedy Index (TI): 45.0 - Tragedy Level: T3 Mourning - M1 (Tragedy): 4.0 | M3 (Satire): 5.0 | M5 (Strategy): 6.0 | M6 (Suspense): 8.0 - N1 (Agency): 0.45 | N2 (Receptivity): 0.55 - K1 (Individual): 0.70 | K2 (Trans-individual): 0.30 - V (Destruction Value): 0.50 | I (Irreversibility): 0.4 | C (Innocence): 0.8 - S (Scope): 0.3 | R (Redemption): 0.35 - Direction Angle theta: 141.3 deg (Contemplative/Withdrawn) - Style Vector: New York Realism / Procedural Noir - Literary Potential E_total: 7.8